Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems. [PDF]
Shrivastava-Ranjan P+10 more
europepmc +1 more source
Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells. [PDF]
Goad DW+3 more
europepmc +1 more source
Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution. [PDF]
Costacurta F+3 more
europepmc +1 more source
Hydrodynamic characterization of a vesicular stomatitis virus-based oncolytic virus using analytical ultracentrifugation. [PDF]
Wawra S+5 more
europepmc +1 more source
Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements. [PDF]
Rauch S+3 more
europepmc +1 more source
Development of a neutralization assay using a vesicular stomatitis virus expressing Nipah virus glycoprotein and a fluorescent protein. [PDF]
Jain S+13 more
europepmc +1 more source
Leveraging Synthetic Virology for the Rapid Engineering of Vesicular Stomatitis Virus (VSV). [PDF]
Moles CM+6 more
europepmc +1 more source
An L (polymerase) deficient rabies virus defective interfering particle RNA is replicated and transcribed by heterologous helper virus proteins [PDF]
Conzelmann, Karl-Klaus+2 more
core
Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations. [PDF]
Abdelmageed AA, Dewhurst S, Ferran MC.
europepmc +1 more source
Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We? [PDF]
Zhang Y, Nagalo BM.
europepmc +1 more source